TAB2 Monoclonal Antibody

The protein encoded by this gene is an activator of MAP3K7/TAK1, which is required for for the IL-1 induced activation of nuclear factor kappaB and MAPK8/JNK. This protein forms a kinase complex with TRAF6, MAP3K7 and TAB1, and it thus serves as an adaptor that links MAP3K7 and TRAF6. This protein, along with TAB1 and MAP3K7, also participates in the signal transduction induced by TNFSF11/RANKl through the activation of the receptor activator of NF-kappaB (TNFRSF11A/RANK), which may regulate the development and function of osteoclasts. Studies of the related mouse protein indicate that it functions to protect against liver damage caused by chemical stressors. Mutations in this gene cause congenital heart defects, multiple types, 2 (CHTD2). Alternative splicing results in multiple transcript variants.

Introducing the TAB2 Monoclonal Antibody, a cutting-edge scientific breakthrough in the field of immunology. This highly advanced product has been meticulously developed by a team of renowned experts to provide unparalleled precision and efficacy in targeting specific antigens.

The TAB2 Monoclonal Antibody boasts an exceptional level of specificity, enabling it to selectively bind to its designated target with utmost accuracy. This remarkable attribute ensures minimal off-target effects, thereby maximizing the therapeutic potential of this antibody.

With its superior affinity and avidity, the TAB2 Monoclonal Antibody exhibits an exceptional binding capacity, facilitating enhanced detection and quantification of the desired antigen. This attribute is particularly advantageous in various research applications, including immunohistochemistry, flow cytometry, and Western blotting.

Furthermore, the TAB2 Monoclonal Antibody offers exceptional stability and consistency, ensuring reliable and reproducible results across multiple experiments. Its robust formulation guarantees long-term storage without compromising its potency, making it an ideal choice for laboratories and research institutions.

In addition to its exceptional performance, the TAB2 Monoclonal Antibody is manufactured in strict compliance with the highest quality standards. Rigorous quality control measures are implemented throughout the production process to guarantee the utmost purity, potency, and reliability of each batch.

The TAB2 Monoclonal Antibody represents a significant advancement in the field of immunology, offering researchers and scientists an invaluable tool to unravel the complexities of various diseases and biological processes. Experience the power of precision and reliability with the TAB2 Monoclonal Antibody and unlock new possibilities in your scientific endeavors.